CytoDyn Inc. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q2 2012 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
CytoDyn Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q2 2012 to Q2 2024.
  • CytoDyn Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending May 31, 2024 was $129M, a 0.04% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $129M +$57K +0.04% May 31, 2024 10-K 2024-08-15
Q2 2023 $129M +$10.9M +9.3% May 31, 2023 10-K 2024-08-15
Q2 2022 $118M +$34.4M +41.3% May 31, 2022 10-K 2024-08-15
Q2 2021 $83.3M +$23.1M +38.5% May 31, 2021 10-K 2022-08-15
Q2 2020 $60.1M +$17M +39.4% May 31, 2020 10-K 2021-07-30
Q2 2019 $43.1M +$6.47M +17.6% May 31, 2019 10-K 2020-08-14
Q2 2018 $36.7M -$707K -1.89% May 31, 2018 10-K 2019-08-14
Q2 2017 $37.4M +$9.41M +33.6% May 31, 2017 10-K 2018-07-27
Q2 2016 $28M +$8.73M +45.3% May 31, 2016 10-K 2017-07-20
Q2 2015 $19.2M +$31.6M May 31, 2015 10-K 2016-07-19
Q2 2014 -$12.4M -$22M -228% May 31, 2014 10-K 2015-07-10
Q2 2013 $9.68M +$1.17M +13.8% May 31, 2013 10-K 2014-07-10
Q2 2012 $8.51M May 31, 2012 10-K 2013-08-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.